Characterization of lghmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)

Katja Grohmann, Wilfried Rossol, Igor Kobsar, Bettina Holtmann, Sibylle Jablonka, Carsten Wessig, Gisela Stoltenburg-Didinger, Utz Fischer, Christoph Hübner, Rudolf Martini, Michael Sendtner

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is caused by recessive mutations of the IGHMBP2 gene. The role of IGHMBP2 (immunoglobulin μ-binding protein 2) in the pathomechanism of motor neuron disease is unknown. We have generated antibodies against Ighmbp2 and showed that low levels of Ighmbp2 immunoreactivity are present in the nucleus of spinal motor neurons and high levels in cell bodies, axons and growth cones. Ighmbp2 protein levels are strongly reduced in neuromuscular degeneration (nmd) mice, the mouse model of SMARD1. Mutant mice show severe motor neuron degeneration before first clinical symptoms become apparent. The loss of motor neuron cell bodies in lumbar spinal cord is followed by axonal degeneration in corresponding nerves such as the femoral quadriceps and sciatic nerve and loss of axon terminals at motor endplates. Motor neuron degeneration and clinical symptoms then slowly progress until the mice die at the age of 3-4 months. In addition, myopathic changes seem to contribute to muscle weakness and especially to respiratory failure, which is characteristic of the disorder in humans. Cultured motor neurons from embryonic nmd mice did not show any abnormality with respect to survival, axonal growth or growth cone size, thus differing from motor neurons derived from, e.g. Smn (survival motor neuron) deficient mice, the model of spinal muscular atrophy (SMA). Our data suggest that the pathomechanism in SMARD1 is clearly distinct from other motor neuron diseases such as classic SMA.

Original languageEnglish (US)
Pages (from-to)2031-2042
Number of pages12
JournalHuman Molecular Genetics
Volume13
Issue number18
DOIs
StatePublished - Sep 15 2004
Externally publishedYes

Fingerprint

Motor Neurons
Spinal Muscular Atrophy
Nerve Degeneration
Growth Cones
Motor Neuron Disease
Spinal Cord
Motor Endplate
Femoral Nerve
Muscle Weakness
Presynaptic Terminals
Sciatic Nerve
Spinal muscular atrophy with respiratory distress 1
Respiratory Insufficiency
Axons
Immunoglobulins
Carrier Proteins
Mutation
Survival
Antibodies
Growth

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Characterization of lghmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1). / Grohmann, Katja; Rossol, Wilfried; Kobsar, Igor; Holtmann, Bettina; Jablonka, Sibylle; Wessig, Carsten; Stoltenburg-Didinger, Gisela; Fischer, Utz; Hübner, Christoph; Martini, Rudolf; Sendtner, Michael.

In: Human Molecular Genetics, Vol. 13, No. 18, 15.09.2004, p. 2031-2042.

Research output: Contribution to journalArticle

Grohmann, K, Rossol, W, Kobsar, I, Holtmann, B, Jablonka, S, Wessig, C, Stoltenburg-Didinger, G, Fischer, U, Hübner, C, Martini, R & Sendtner, M 2004, 'Characterization of lghmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)', Human Molecular Genetics, vol. 13, no. 18, pp. 2031-2042. https://doi.org/10.1093/hmg/ddh222
Grohmann, Katja ; Rossol, Wilfried ; Kobsar, Igor ; Holtmann, Bettina ; Jablonka, Sibylle ; Wessig, Carsten ; Stoltenburg-Didinger, Gisela ; Fischer, Utz ; Hübner, Christoph ; Martini, Rudolf ; Sendtner, Michael. / Characterization of lghmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1). In: Human Molecular Genetics. 2004 ; Vol. 13, No. 18. pp. 2031-2042.
@article{561a8737ba0544fab3bb8d5739464af6,
title = "Characterization of lghmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)",
abstract = "Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is caused by recessive mutations of the IGHMBP2 gene. The role of IGHMBP2 (immunoglobulin μ-binding protein 2) in the pathomechanism of motor neuron disease is unknown. We have generated antibodies against Ighmbp2 and showed that low levels of Ighmbp2 immunoreactivity are present in the nucleus of spinal motor neurons and high levels in cell bodies, axons and growth cones. Ighmbp2 protein levels are strongly reduced in neuromuscular degeneration (nmd) mice, the mouse model of SMARD1. Mutant mice show severe motor neuron degeneration before first clinical symptoms become apparent. The loss of motor neuron cell bodies in lumbar spinal cord is followed by axonal degeneration in corresponding nerves such as the femoral quadriceps and sciatic nerve and loss of axon terminals at motor endplates. Motor neuron degeneration and clinical symptoms then slowly progress until the mice die at the age of 3-4 months. In addition, myopathic changes seem to contribute to muscle weakness and especially to respiratory failure, which is characteristic of the disorder in humans. Cultured motor neurons from embryonic nmd mice did not show any abnormality with respect to survival, axonal growth or growth cone size, thus differing from motor neurons derived from, e.g. Smn (survival motor neuron) deficient mice, the model of spinal muscular atrophy (SMA). Our data suggest that the pathomechanism in SMARD1 is clearly distinct from other motor neuron diseases such as classic SMA.",
author = "Katja Grohmann and Wilfried Rossol and Igor Kobsar and Bettina Holtmann and Sibylle Jablonka and Carsten Wessig and Gisela Stoltenburg-Didinger and Utz Fischer and Christoph H{\"u}bner and Rudolf Martini and Michael Sendtner",
year = "2004",
month = "9",
day = "15",
doi = "10.1093/hmg/ddh222",
language = "English (US)",
volume = "13",
pages = "2031--2042",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "18",

}

TY - JOUR

T1 - Characterization of lghmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)

AU - Grohmann, Katja

AU - Rossol, Wilfried

AU - Kobsar, Igor

AU - Holtmann, Bettina

AU - Jablonka, Sibylle

AU - Wessig, Carsten

AU - Stoltenburg-Didinger, Gisela

AU - Fischer, Utz

AU - Hübner, Christoph

AU - Martini, Rudolf

AU - Sendtner, Michael

PY - 2004/9/15

Y1 - 2004/9/15

N2 - Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is caused by recessive mutations of the IGHMBP2 gene. The role of IGHMBP2 (immunoglobulin μ-binding protein 2) in the pathomechanism of motor neuron disease is unknown. We have generated antibodies against Ighmbp2 and showed that low levels of Ighmbp2 immunoreactivity are present in the nucleus of spinal motor neurons and high levels in cell bodies, axons and growth cones. Ighmbp2 protein levels are strongly reduced in neuromuscular degeneration (nmd) mice, the mouse model of SMARD1. Mutant mice show severe motor neuron degeneration before first clinical symptoms become apparent. The loss of motor neuron cell bodies in lumbar spinal cord is followed by axonal degeneration in corresponding nerves such as the femoral quadriceps and sciatic nerve and loss of axon terminals at motor endplates. Motor neuron degeneration and clinical symptoms then slowly progress until the mice die at the age of 3-4 months. In addition, myopathic changes seem to contribute to muscle weakness and especially to respiratory failure, which is characteristic of the disorder in humans. Cultured motor neurons from embryonic nmd mice did not show any abnormality with respect to survival, axonal growth or growth cone size, thus differing from motor neurons derived from, e.g. Smn (survival motor neuron) deficient mice, the model of spinal muscular atrophy (SMA). Our data suggest that the pathomechanism in SMARD1 is clearly distinct from other motor neuron diseases such as classic SMA.

AB - Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is caused by recessive mutations of the IGHMBP2 gene. The role of IGHMBP2 (immunoglobulin μ-binding protein 2) in the pathomechanism of motor neuron disease is unknown. We have generated antibodies against Ighmbp2 and showed that low levels of Ighmbp2 immunoreactivity are present in the nucleus of spinal motor neurons and high levels in cell bodies, axons and growth cones. Ighmbp2 protein levels are strongly reduced in neuromuscular degeneration (nmd) mice, the mouse model of SMARD1. Mutant mice show severe motor neuron degeneration before first clinical symptoms become apparent. The loss of motor neuron cell bodies in lumbar spinal cord is followed by axonal degeneration in corresponding nerves such as the femoral quadriceps and sciatic nerve and loss of axon terminals at motor endplates. Motor neuron degeneration and clinical symptoms then slowly progress until the mice die at the age of 3-4 months. In addition, myopathic changes seem to contribute to muscle weakness and especially to respiratory failure, which is characteristic of the disorder in humans. Cultured motor neurons from embryonic nmd mice did not show any abnormality with respect to survival, axonal growth or growth cone size, thus differing from motor neurons derived from, e.g. Smn (survival motor neuron) deficient mice, the model of spinal muscular atrophy (SMA). Our data suggest that the pathomechanism in SMARD1 is clearly distinct from other motor neuron diseases such as classic SMA.

UR - http://www.scopus.com/inward/record.url?scp=5744242172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5744242172&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddh222

DO - 10.1093/hmg/ddh222

M3 - Article

C2 - 15269181

AN - SCOPUS:5744242172

VL - 13

SP - 2031

EP - 2042

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 18

ER -